Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, which includes the makers of Xarelto reco Has, possess a duty to make sure that their drugs are reasonably secure for use - and failure to perform so may possibly be grounds for compensation. Our lawyers are working tough to acquire those hurt by the drug the compensation they may be entitled to.

(Image: https://images15.fotki.com/v398/photos/4/3761384/14266508/Saimoonsaimoon_co-vi.jpg)Although bleeding is actually a typical complication linked with anticoagulants, it has been alleged that Xarelto is more dangerous than traditional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This implies that, within the event of an emergency, patients may possibly be at threat for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.

In case you or possibly a loved one suffered a serious bleeding event right after taking Xarelto, you might have legal recourse. For a lot more info, speak to us today to possess your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Additionally, they're in search of punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

(Image: http://media5.picsearch.com/is?IffHNIoouNIDhdT2OeagqSYhxjn0b_lw0YxnQjzF2t0&height=248)The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Discussion

Enter your comment (wiki syntax is allowed):

Personal Tools